The findings of this study indicate that SOX2 may be a key player in the dedifferentiation of lung cancer cells, as demonstrated by the higher levels of upregulated SOX2 expression seen in dedifferentiated CSCs derived from non-CSCs. This evidence concerns the gene SOX2 and lung carcinoma.